Auna S.A. (NYSE:AUNA – Get Free Report) President Leon Jesus Zamora acquired 9,220 shares of the company’s stock in a transaction that occurred on Thursday, May 28th. The shares were acquired at an average price of $4.17 per share, with a total value of $38,447.40. Following the acquisition, the president owned 55,134 shares in the company, valued at $229,908.78. This trade represents a 20.08% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Leon Jesus Zamora also recently made the following trade(s):
- On Friday, May 29th, Leon Jesus Zamora acquired 6,420 shares of Auna stock. The shares were acquired at an average price of $4.15 per share, with a total value of $26,643.00.
- On Tuesday, May 26th, Leon Jesus Zamora acquired 30,000 shares of Auna stock. The shares were acquired at an average price of $4.39 per share, with a total value of $131,700.00.
- On Wednesday, May 20th, Leon Jesus Zamora acquired 5,814 shares of Auna stock. The shares were acquired at an average price of $4.39 per share, with a total value of $25,523.46.
- On Wednesday, May 27th, Leon Jesus Zamora acquired 23,273 shares of Auna stock. The shares were acquired at an average price of $4.20 per share, with a total value of $97,746.60.
- On Tuesday, May 26th, Leon Jesus Zamora acquired 8,727 shares of Auna stock. The shares were acquired at an average price of $4.24 per share, with a total value of $37,002.48.
Auna Price Performance
AUNA opened at $4.51 on Thursday. The business has a fifty day moving average of $5.15 and a 200 day moving average of $5.01. Auna S.A. has a 52-week low of $4.09 and a 52-week high of $6.85. The company has a quick ratio of 1.00, a current ratio of 1.09 and a debt-to-equity ratio of 1.76. The stock has a market cap of $333.56 million, a P/E ratio of 17.34 and a beta of 0.81.
Analyst Ratings Changes
A number of equities research analysts recently weighed in on the company. Wall Street Zen cut Auna from a “strong-buy” rating to a “buy” rating in a research note on Saturday, May 16th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Auna in a research report on Friday, March 27th. JPMorgan Chase & Co. reduced their target price on Auna from $6.00 to $5.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 26th. Finally, Zacks Research lowered Auna from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, March 31st. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $6.97.
Get Our Latest Stock Analysis on AUNA
Institutional Inflows and Outflows
Hedge funds have recently modified their holdings of the company. World Investment Advisors acquired a new position in shares of Auna in the fourth quarter valued at about $52,000. Clear Harbor Asset Management LLC acquired a new position in shares of Auna in the fourth quarter valued at about $63,000. Sanctuary Advisors LLC acquired a new position in shares of Auna in the first quarter valued at about $71,000. Virtu Financial LLC acquired a new position in shares of Auna in the third quarter valued at about $75,000. Finally, Sage Investment Counsel LLC increased its holdings in shares of Auna by 60.0% in the fourth quarter. Sage Investment Counsel LLC now owns 16,000 shares of the company’s stock valued at $79,000 after purchasing an additional 6,000 shares during the period.
Auna Company Profile
Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna’s organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.
The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines.
Recommended Stories
- Five stocks we like better than Auna
- Coke’s $10B India IPO Plan Pops the Top on Hidden Value
- FedEx Unboxes Billions in Post-Spinoff Value
- Marvell’s AI Moment Raises a Bigger Question for Amazon and ServiceNow
- Palo Alto Networks Accelerates Growth 31% on AI Demand
Receive News & Ratings for Auna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Auna and related companies with MarketBeat.com's FREE daily email newsletter.
